DE3875425D1 - Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen. - Google Patents

Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.

Info

Publication number
DE3875425D1
DE3875425D1 DE8888111306T DE3875425T DE3875425D1 DE 3875425 D1 DE3875425 D1 DE 3875425D1 DE 8888111306 T DE8888111306 T DE 8888111306T DE 3875425 T DE3875425 T DE 3875425T DE 3875425 D1 DE3875425 D1 DE 3875425D1
Authority
DE
Germany
Prior art keywords
vasokinetic
acids
polyunsacted
activating
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888111306T
Other languages
English (en)
Other versions
DE3875425T2 (de
Inventor
Ezio Bombardelli
Sergio B Curri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of DE3875425D1 publication Critical patent/DE3875425D1/de
Publication of DE3875425T2 publication Critical patent/DE3875425T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE8888111306T 1987-07-27 1988-07-14 Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen. Expired - Fee Related DE3875425T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21453/87A IT1223290B (it) 1987-07-27 1987-07-27 Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche

Publications (2)

Publication Number Publication Date
DE3875425D1 true DE3875425D1 (de) 1992-11-26
DE3875425T2 DE3875425T2 (de) 1993-03-11

Family

ID=11181998

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888111306T Expired - Fee Related DE3875425T2 (de) 1987-07-27 1988-07-14 Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.

Country Status (7)

Country Link
US (1) US5104655A (de)
EP (1) EP0304603B1 (de)
AT (1) ATE81588T1 (de)
DE (1) DE3875425T2 (de)
ES (1) ES2052645T3 (de)
GR (1) GR3006068T3 (de)
IT (1) IT1223290B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4006563C2 (de) * 1988-09-02 1994-06-30 Reutter Werner Verwendung von Phosphatesterderivaten als Wirkstoffe in Kosmetika und sie enthaltende kosmetische Präparate
DE4022815A1 (de) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
WO1992011036A1 (en) * 1990-12-21 1992-07-09 Wade, Jonathan, Leslie Adjuvants containing unsaturated lipid
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
IT1251497B (it) * 1991-09-18 1995-05-15 Mivett Nuovi Lab Di Pavani& C Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
IT1251840B (it) * 1991-09-20 1995-05-26 Schiena Ricerche Uso di formulazioni liposomiali contenenti papaverina nel trattamento della impotenza maschile
FR2698269B1 (fr) * 1992-11-24 1995-01-06 Inst Nat Sante Rech Med Nouveaux médicaments à base d'acides gras insaturés, utilisables notamment comme antiagrégants plaquettaires et/ou comme transporteurs privilégiés vers le cerveau.
EP0640581A1 (de) * 1993-08-25 1995-03-01 Biox Corporation Endermischer Nährstoff und diesen enthaltende kosmetische Zusammensetzung
US5411988A (en) * 1993-10-27 1995-05-02 Bockow; Barry I. Compositions and methods for inhibiting inflammation and adhesion formation
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
IT1278997B1 (it) * 1994-07-19 1997-12-02 Indena Spa Combinazioni di sostanze vasoattive con acidi grassi per combattere la caduta dei capelli
DE69637953D1 (de) 1995-04-17 2009-07-30 Nat Inst Of Advanced Ind Scien Hoch ungesättigte fettsäurenproduzierende mikroorganismen und verfahren zur herstellung von hoch ungesättigten fettsäuren durch verwendung dieser mikroorganismen
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
IT1284971B1 (it) * 1996-10-17 1998-05-28 Indena Spa Formulazioni farmaceutiche e cosmetiche ad attivita' antiacne
US6267996B1 (en) 1996-10-17 2001-07-31 Indena S.P.A Pharmaceutical and cosmetic formulations with antimicrobial activity
TW592719B (en) * 1997-03-26 2004-06-21 Shiseido Co Ltd Hair growth phase extender composition containing unsaturated fatty acid and/or its derivatives or an extract of a plant belonging to the Coriandrum
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
GB2331528B (en) * 1997-11-20 2002-03-13 Unilever Plc Hair treatment composition
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) * 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US20020197244A1 (en) * 1998-12-07 2002-12-26 Miri Seiberg Compositions and methods for regulating phagocytosis and ICAM-1 expression
US7985404B1 (en) * 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
GB9918023D0 (en) 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) * 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
ITMI20011182A1 (it) * 2001-06-05 2002-12-05 Indena Spa Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
EP1402787A1 (de) 2002-09-27 2004-03-31 Loders Croklaan B.V. Ximeninsäure
CA2506611A1 (en) * 2002-11-22 2004-06-10 Nippon Suisan Kaisha Ltd. External composition containing polyunsaturated fatty acid or its salt or ester
US20050004561A1 (en) * 2003-07-01 2005-01-06 Lynn Halas Method for removing hair
ITMI20031428A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
CA2543540A1 (en) * 2003-10-29 2005-06-02 Johnson & Johnson Consumer France S.A.S. Compositions comprising soy products and dioic acids
US20050158258A1 (en) * 2004-01-21 2005-07-21 Mary Kay Inc. Methods and compositions for the treatment of skin changes associated with aging and environmental damage
DE102005061071A1 (de) * 2005-12-21 2007-06-28 Kneipp-Werke Kneipp-Mittel-Zentrale Gmbh & Co. Kg Wirkstoffkombination aus Santalbinsäure oder Derivate davon und Traubenkernöl zur topischen oder dermatologischen Verwendung
US20080008818A1 (en) * 2006-06-23 2008-01-10 Miri Seiberg Partially denatured whole soybean extracts and methods of use thereof
US20080089960A1 (en) * 2006-10-16 2008-04-17 Miri Seiberg Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage
US20100173014A1 (en) * 2007-05-24 2010-07-08 Nanosolutions, Llc Methods of making and using nano scale particles
DE102008032327A1 (de) * 2008-07-09 2010-01-14 Rovi Cosmetics International Gmbh Kosmetisches oder pharmazeutisches Präparat zur topischen Applikation von mehrfach ungesättigten Fettsäuren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
GB8319073D0 (en) 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions

Also Published As

Publication number Publication date
IT1223290B (it) 1990-09-19
IT8721453A0 (it) 1987-07-27
DE3875425T2 (de) 1993-03-11
GR3006068T3 (de) 1993-06-21
ATE81588T1 (de) 1992-11-15
US5104655A (en) 1992-04-14
EP0304603A1 (de) 1989-03-01
EP0304603B1 (de) 1992-10-21
ES2052645T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
DE3875425D1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
ATE92930T1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ATE75397T1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
ZA885192B (en) Pharmaceutical preparations
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
DE59105808D1 (de) Verwendung von pharmazeutischen und kosmetischen Präparaten mit Mischmicellen.
ES2058420T3 (es) Preparados farmaceuticos combinados y su utilizacion como medicamentos antineoplasicos.
ATE113650T1 (de) Ausgewählte stämme von lactobacillus enthaltende pharmazeutische zusammensetzungen.
DE3883016D1 (de) Komplexe verbindungen aus bioflavonoiden mit phospholipiden, ihre herstellung und verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ES2054919T3 (es) Acidos y esteres 4-(quinolin-2-il-metoxi)fenilaceticos alfa-substituidos en caso dado.
ES2073533T3 (es) Uso antivirico de composiciones que constan de acidos grasos esenciales e interferon.
ATE22532T1 (de) Pharmazeutische zusammensetzung.
DE68901105D1 (de) Alkensaeurederivate.
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
ATE99945T1 (de) Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
DE59101404D1 (de) Topische Präparate.
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE3863200D1 (de) In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen.
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
FI891210A0 (fi) Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.
SE8902624D0 (sv) New pharmaceutical preparations
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
FI851365L (fi) Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee